![](/img/cover-not-exists.png)
Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trial
Dreger, P., Dohner, H., Ritgen, M., Bottcher, S., Busch, R., Dietrich, S., Bunjes, D., Cohen, S., Schubert, J., Hegenbart, U., Beelen, D., Zeis, M., Stadler, M., Hasenkamp, J., Uharek, L., Scheid, C.,Volume:
116
Language:
english
Journal:
Blood
DOI:
10.1182/blood-2010-03-275420
Date:
October, 2010
File:
PDF, 326 KB
english, 2010